AkizukiN, AkechiT, NakanishiT, YoshikawaE, OkamuraM, NakanoT, MurakamiY, UchitomiY. Development of brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer, 97:2605–2613. 2003.
2.
ArbaizerB, Dierssen–SotosT, Gomez–AceboI, LloorcaJ. Aripiprazole in major depression and mania: Meta-analyses of randomized placebo-controlled trials. Gen Hosp Psychiatry, 31:478–483. 2009.
3.
ClarkDB, AndrusMR, ByrdDC. Drug interactions between linezolid and selective serotonin reuptake inhibitors: Case report involving sertraline and review of literature. Pharmacotherapy, 26:269–276. 2006.
4.
DelBelloMP, ChangK, WelgeJA, AdlerCM, RanaM, HoweM, BryanH, VogelD, SampangS, DelgadoSV, SorterM, StrakowskiSM. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord, 11:483–493. 2009.
5.
GeddesJR, CalabreseJR, GoodwinGM. Lamotrigine for treatment of bipolar depression: Independent meta-analysis and meta regression of individual patient data from five randomized trials. Br J Psychiatry, 194:4–9. 2009.
6.
GraberMA, HoehnsTB, PerryPJ. Sertraline-phenelzine drug reaction: A serotonin syndrome reaction. Ann Pharmacother, 28:732–735. 1994.
7.
HilliJ, KorhonenT, LaineK. Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram. Prog Neuropsychopharmacol Biol Psychiatry, 13:1526–1532. 2009.
8.
HodgmanMJ, MartinTG, KrenzelokEP. Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy. Hum Exp Toxicol, 16:14–17. 1997.
9.
KersunLS, EliaJ. Depressive symptoms and SSRI use in oncology patients. Pediatr Blood Cancer, 49:881–887. 2007.
10.
KomossaK, DeppingAM, GaudchauA, KisslingW, LeuchtS. Second generation antipsychotics for major depressive disorder, dysthymia. Cochrane Database Syst Rev, 12:CD008121. 2010.
11.
LiebowitzM, LamRW, LepolaU, DattoC, SweitzerD, ErikssonH. Efficacy and tolerability of extended release qutiapine fumarate monotherapy as maintenance treatment for major depressive disorder: Randomized placebo-controlled trial. Depress Anxiety, 27:964–976. 2010.
12.
MassoudM, ArmandJP, RibragV. Procarbazine in hematology: An old drug with a new life?Eur J Cancer, 40:1924–1927. 2004.
13.
MiovicM, BlockS. Psychiatric disorders in advanced cancer. Cancer, 110:1665–1676. 2007.
14.
NeuvonenPJ, Pohjola–SintonenS, TackeU, VuoriE. Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses. Lancet, 342:1419. 1993.
15.
Physicians' Desk Reference, 64th. Montvale (New Jersey): Thompson PDR, 2010.
16.
SanfordM, KeatingGM. Quetiapine: A review of its use in the management of bipolar depression. CNS Drugs, 26:435–460. 2012.
17.
StahlSM, FelkerA. Monoamine oxidase inhibitors: A modern guide to an unrequited class of antidepressants. CNS Spectr, 13:855–870. 2008.
18.
YapKY-L, ChuiWK, ChanA. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther, 30:1385–1407. 2008.
19.
YapKY-L, TayWL, ChuiWK, ChanA. Clinically relevant drug interactions between anticancer drugs and psychotropic agents. Eur J Cancer Care, 20:6–32. 2011.
20.
ZaboraJ, BritzenhofeSzocK, CurbowB, HookerC, PiantadosiS. The prevalence of psychological distress by cancer site. Psychooncology, 10:19–28. 2001.
